268 related articles for article (PubMed ID: 32677996)
21. Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial.
Liu J; Liu B; Liu J; Wen D; Wang M; Shao Y; Li X
BMC Ophthalmol; 2023 Dec; 23(1):504. PubMed ID: 38087284
[TBL] [Abstract][Full Text] [Related]
22. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Lee BJ; Yu HG
Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
[TBL] [Abstract][Full Text] [Related]
23. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
[TBL] [Abstract][Full Text] [Related]
24. Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study.
Wang S; Liu Y; Du Y; Bao H; Zhu J; Liu X
BMC Ophthalmol; 2023 Jul; 23(1):309. PubMed ID: 37430223
[TBL] [Abstract][Full Text] [Related]
25. Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients.
Zhao M; Chandra A; Xu J; Li J
BMC Ophthalmol; 2023 May; 23(1):215. PubMed ID: 37189104
[TBL] [Abstract][Full Text] [Related]
26. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Immediate and Delayed Vitrectomy for the Management of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy.
Fassbender JM; Ozkok A; Canter H; Schaal S
Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):35-41. PubMed ID: 26731207
[TBL] [Abstract][Full Text] [Related]
28. Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy.
Motoda S; Shiraki N; Ishihara T; Sakaguchi H; Kabata D; Takahara M; Kimura T; Kozawa J; Imagawa A; Nishida K; Shintani A; Iwahashi H; Shimomura I
J Diabetes Investig; 2018 Jul; 9(4):940-945. PubMed ID: 29265703
[TBL] [Abstract][Full Text] [Related]
29. Air-Perfused 23-Gauge Sutureless Diabetic Vitrectomy for Control of Intraoperative Bleeding during Removal of Fibrovascular Membrane.
Kim YJ; Seo H; Lee DY; Nam DH
Curr Eye Res; 2019 Mar; 44(3):334-340. PubMed ID: 30311807
[TBL] [Abstract][Full Text] [Related]
30. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
Li X; Jiang Y; Ye C; Li C
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
[TBL] [Abstract][Full Text] [Related]
31. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
32. Vitrectomy surgery of diabetic retinopathy complications.
Brănişteanu DC; Bilha A; Moraru A
Rom J Ophthalmol; 2016; 60(1):31-6. PubMed ID: 27220230
[TBL] [Abstract][Full Text] [Related]
33. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.
Hershberger VS; Augsburger JJ; Hutchins RK; Raymond LA; Krug S
Ophthalmology; 2004 Jun; 111(6):1215-21. PubMed ID: 15177974
[TBL] [Abstract][Full Text] [Related]
34. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
Retina; 2009; 29(7):926-31. PubMed ID: 19584650
[TBL] [Abstract][Full Text] [Related]
35. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
36. Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy.
Naruse Z; Shimada H; Mori R
Int Ophthalmol; 2019 Sep; 39(9):1973-1980. PubMed ID: 30284092
[TBL] [Abstract][Full Text] [Related]
37. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the 20-gauge conventional vitrectomy technique with the 23-gauge releasable suture vitrectomy technique.
Kim IG; Lee SJ; Park JM
Korean J Ophthalmol; 2013 Feb; 27(1):12-8. PubMed ID: 23372374
[TBL] [Abstract][Full Text] [Related]
39. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
40. 25-Gauge sutureless vitrectomy versus 20-gauge vitrectomy for the repair of primary rhegmatogenous retinal detachment.
Von Fricken MA; Kunjukunju N; Weber C; Ko G
Retina; 2009 Apr; 29(4):444-50. PubMed ID: 19174723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
